03/13/2026
For a long time, womenâs low libido was explained away as stress, relationship issues, or simply âgetting older.â
But the science of sexual desire tells a much more complex story.
Desire is shaped by an intricate interaction between hormones, brain chemistry, physiology, psychology, and overall health.
The documentary The Little Pink Pill explores the debate surrounding Hypoactive Sexual Desire Disorder (HSDD) and the approval of Flibanserin â the first medication developed specifically to treat low sexual desire in women.
The conversation it sparked raised important questions:
How do we define sexual desire in women?
When does a shift in libido become a medical concern?
And why has research into womenâs sexual health historically lagged so far behind menâs?
What current science makes clear is that sexual desire is influenced by multiple biological systems working together:
Estrogen and testosterone
Neurotransmitters like dopamine and serotonin
Stress and nervous system regulation
Sleep and metabolic health
And for many women, the hormonal shifts of perimenopause and menopause can also play a significant role.
Changes in estrogen, testosterone availability, sleep quality, mood regulation, and vaginal tissue health can all influence desire during this stage of life. For some women, libido changes are temporary. For others, they can be persistent and distressing.
Thatâs why understanding the why behind changes in desire matters.
Women deserve evidence-based information, thoughtful care, and open conversations about sexual health â especially during midlife, when these shifts often begin.
Have you seen the documentary?
Curious what you think about the conversation it sparked.